Prevention of ovariectomy-induced changes in the Sprague-Dawley rat by the selective estrogen receptor modulator HMR 3339.

被引：0
|
作者：
Smith, SY
Jolette, J
Leyshon, AM
Turner, CH
Gaillard-Kelly, M
Vidal, JM
Baron, R
机构：
[1] Proskelia, Romainville, France
[2] Aventis Pharma, Romainville, France
[3] Indiana Univ, Indianapolis, IN 46204 USA
[4] CTBR, Montreal, PQ, Canada
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M379
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 48 条
  • [1] In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator
    Arshad, A
    Sengupta, S
    Sharma, S
    Ghosh, R
    Sawlani, V
    Singh, MM
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 91 (1-2): : 67 - 78
  • [2] The decrease in bone mineral mass and in bone strength induced by ovariectomy in adult rats is corrected by the new selective estrogen receptor modulator HMR 3339.
    Ammann, P
    Brunner, F
    Gaillard, M
    Meyer, JM
    Rizzoli, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S481 - S481
  • [3] The new selective estrogen receptor modulator HMR 3339 prevents ovariectomy-induced bone loss and alteration of bone strength in adult rats.
    Ammann, P
    Bourrin, S
    Brunner, F
    Gaillard, M
    Meyer, JM
    Rizzoli, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S481 - S481
  • [4] A new selective estrogen receptor modulator HMR-3339 fully corrects bone alterations induced by ovariectomy in adult rats
    Ammann, P
    Bourrin, S
    Brunner, F
    Meyer, JM
    Clément-Lacroix, P
    Baron, R
    Gaillard, M
    Rizzoli, R
    BONE, 2004, 35 (01) : 153 - 161
  • [5] Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats
    Weisenburger, WP
    Hagler, AR
    Tassinari, MS
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2004, 71 (03) : 171 - 184
  • [6] Metabolism of levormeloxifene, a selective oestrogen receptor modulator, in the Sprague-Dawley rat, Cynomolgus monkey and postmenopausal woman
    Mountfield, RJ
    Panduro, AM
    Wassmann, O
    Thompson, M
    John, B
    van der Merbel, N
    XENOBIOTICA, 2000, 30 (02) : 201 - 217
  • [7] Ovariectomy-Induced Hyperphagia Does Not Modulate Bone Mineral or Bone Strength in Female Sprague-Dawley Rats
    Jiang, J. M. Y.
    Sacco, S. N.
    Ward, W. E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S217 - S217
  • [8] Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women
    Vogelvang, TE
    Mijatovic, V
    Kenemans, P
    Schalkwijk, CG
    van der Mooren, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (09): : 1205 - 1208
  • [9] NUCLEOTIDE-SEQUENCE OF ESTROGEN-RECEPTOR CDNA FROM SPRAGUE-DAWLEY RAT
    SPREAFICO, E
    BETTINI, E
    POLLIO, G
    MAGGI, A
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (03): : 353 - 356
  • [10] Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats
    Ghosh, R
    Kamboj, VP
    Singh, MM
    CONTRACEPTION, 2001, 64 (04) : 261 - 269
12345